Amedisys Inc
NASDAQ:AMED
Amedisys Inc
Tax Provision
Amedisys Inc
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amedisys Inc
NASDAQ:AMED
|
Tax Provision
-$53.4m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Tax Provision
-$241.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Tax Provision
-$249m
|
CAGR 3-Years
25%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
7%
|
|
CVS Health Corp
NYSE:CVS
|
Tax Provision
-$2.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
Cigna Corp
NYSE:CI
|
Tax Provision
-$137m
|
CAGR 3-Years
62%
|
CAGR 5-Years
34%
|
CAGR 10-Years
18%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Tax Provision
-$193.7m
|
CAGR 3-Years
39%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
See Also
What is Amedisys Inc's Tax Provision?
Tax Provision
-53.4m
USD
Based on the financial report for Mar 31, 2024, Amedisys Inc's Tax Provision amounts to -53.4m USD.
What is Amedisys Inc's Tax Provision growth rate?
Tax Provision CAGR 5Y
-6%
Over the last year, the Tax Provision growth was -33%. The average annual Tax Provision growth rates for Amedisys Inc have been -16% over the past three years , -6% over the past five years .